Bioverse review
States listed, price hidden
A longevity telehealth platform offering NAD⁺ and glutathione on subscription, which names the eighteen states it serves and none of its prices.
Our verdict
Bioverse does something most of this board avoids: it names the eighteen states it actually operates in instead of implying nationwide coverage, and it states plainly that there are no membership, cancellation, doctor or hidden fees. Both are worth crediting. What it will not show you is a price for anything on the longevity menu, and it displays no accreditation seal or named pharmacy to compensate.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.
At a glance
- Category
- NAD⁺ telehealth
- Access
- Eighteen named states; monthly subscription, NAD⁺ pricing not published
- Insurance
- Cash-pay, no insurance
- Visit
- Async intake
- Availability
- 18 states: AZ, CA, CO, FL, GA, IL, IN, MD, MA, MI, NJ, NY, NC, OH, PA, TX, VA, WA
- Updated
- July 2026
Popular alternative
Enhance MD
Physician-supervised NAD⁺ under lab-guided oversight
Check Enhance MD availability →What it is
Bioverse, trading as GoBioverse, is a telehealth and longevity platform whose menu spans NAD⁺ injections and glutathione injections on monthly subscription, B12 on a quarterly schedule, metformin, and both compounded and brand-name GLP-1 medication including Ozempic, Wegovy and Mounjaro. It states its medication is prescribed by U.S.-licensed providers and delivered from FDA-regulated pharmacies, with free discreet shipping. At our live check it listed availability in eighteen named states.
How it works
Online intake, a licensed provider licensed in your state reviews it, and product ships on subscription — NAD⁺ and glutathione monthly, B12 quarterly, metformin in 90-dose blocks. The subscription cadence is at least legible, which is more than a per-session infusion clinic offers. Two structural points sit on the plus side: the eighteen-state list is published rather than claimed, and the company states there are no membership, cancellation, doctor or hidden fees, which removes the layered-fee model common elsewhere. On the minus side, no compounding pharmacy is named — "FDA-regulated pharmacies" is a category, not an identity — no LegitScript or PCAB accreditation is displayed, and no lab work sits in the default path. This is also a broad longevity storefront rather than an NAD⁺ practice, so the NAD⁺ product comes with no published protocol, dose rationale or monitoring plan.
Pricing transparency
No NAD⁺ price is published, so we are not quoting one. Bioverse does publish compounded GLP-1 pricing, but those are weight-loss figures tied to plan length — the lowest of them attaches to a twelve-month commitment rather than being a flat rate — and they say nothing about what an NAD⁺ or glutathione subscription costs. The fee disclosure is the useful part of the pricing story: no membership, cancellation, doctor or hidden fees, with free shipping. Ask directly what the monthly NAD⁺ subscription costs, what vial size and dose it supplies, whether the price is tied to a plan length the way the GLP-1 line is, and what happens if you pause.
Branded vs compounded
Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. The NAD⁺ and glutathione injections are compounding-pharmacy preparations and are not therapeutically equivalent to any approved drug, and the pharmacy behind them is not named — a real gap, because compounded sterile products are not FDA-reviewed for purity and potency the way approved drugs are. The brand-name GLP-1s Bioverse also offers are FDA-approved, and the two tiers should not be conflated. On the evidence, the longevity line needs stating plainly. Injected NAD⁺ has no controlled human outcome trials supporting the energy, focus or longevity claims attached to it; the one human intravenous study was a pharmacokinetic pilot showing infused NAD⁺ clears from plasma quickly. The NAD⁺ evidence that exists belongs to the oral precursors NR and NMN, which reliably raise blood NAD⁺ in controlled studies — a raised biomarker, not a demonstrated clinical outcome. Injectable glutathione has essentially no controlled human outcome evidence for the wellness and skin claims made about it. Individual results vary.
Pros and watch-outs
What we like
- Eighteen states named explicitly rather than a vague nationwide claim
- States there are no membership, cancellation, doctor or hidden fees
- NAD⁺ and glutathione sold on a legible monthly subscription with vial sizes shown
- Wide formulary — compounded and brand-name GLP-1s, metformin, B12 — in one place
- Free discreet shipping, with prescribing by U.S.-licensed providers
Watch-outs
- No NAD⁺ or glutathione price published anywhere
- No named compounding pharmacy — only "FDA-regulated pharmacies"
- No LegitScript or PCAB accreditation displayed
- A broad longevity storefront rather than an NAD⁺ practice, with no published protocol
- Injected NAD⁺ and glutathione both lack controlled human outcome data
Best for
People in one of its eighteen states who want NAD⁺ on a straightforward monthly subscription with no membership or doctor fees layered on top.
Who should look elsewhere
Anyone outside those states, anyone who needs to see a price before enrolling, or anyone who wants a named pharmacy and a documented NAD⁺ protocol.
The evidence behind what Bioverse prescribes
We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.
- NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.
- Glutathione: the master antioxidant, and where the evidence actually is
Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.
How Bioverse compares
A few alternatives worth a look, depending on what you’re optimizing for.
- Restore Hyper Wellness
In-person NAD⁺ IV or IM shots at a national studio chain
See Restore Hyper Wellness → - Drip Hydration
At-home / concierge NAD⁺ IV infusions
See Drip Hydration → - Tru Niagen
The most clinically-studied oral NAD⁺ precursor (NR)
See Tru Niagen →
Access & cost · Reviewed and last verified July 2026
How we assessed this. This review reflects Aminoscope’s own read of Bioverse’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Where is Bioverse available?
- At our live check it listed eighteen states: Arizona, California, Colorado, Florida, Georgia, Illinois, Indiana, Maryland, Massachusetts, Michigan, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Texas, Virginia and Washington. Naming them is better practice than the vague nationwide claims elsewhere on this board, and it is the first thing to check.
- What does NAD⁺ cost at Bioverse?
- It is not published, so we are not quoting a figure. Only the GLP-1 line carries public pricing, and those figures are tied to plan length rather than being flat rates. Ask what the monthly NAD⁺ subscription costs, what vial size and dose it supplies, and whether the price depends on a longer commitment.
- Does Bioverse charge membership or consultation fees?
- It states it does not — no membership, cancellation, doctor or hidden fees, with free shipping. That removes the layered-fee structure common in this category, though it does not tell you what the medication itself costs, which is the number still missing.
- Is injected NAD⁺ better than an oral precursor?
- Not on the evidence. Injected NAD⁺ has no controlled human outcome trials, and the one human intravenous study was a pharmacokinetic pilot showing it clears from plasma quickly. Oral NR and NMN are the forms with controlled human data, and what that data shows is a raised blood NAD⁺ level rather than a demonstrated clinical benefit.